Johnson & Johnson

NYSE: JNJ
$164.52
-$0.31 (-0.2%)
Real Time Data Delayed 15 Min.

JNJ Articles

What to expect from upcoming earnings reports from American Express, Johnson & Johnson, Microsoft and other Dow components.
The top analyst upgrades, downgrades and other research calls from Thursday include AbbVie, Amazon.com, Anadarko, Broadcom, Chipotle Mexican Grill, ConocoPhiilips, General Electric, Honeywell,...
Intel, Walgreens, Johnson & Johnson, and Merck led the Dow higher Thursday.
Some investors track what some might call the "pigs of the Dow" as the top laggards of the index. After all, great companies that get beaten down do not always stay down forever. Some come back with...
General Electric is being dropped from its spot on the Dow Jones industrial average index and it leaves with the dubious distinction of being the worst performing Dow stock for the year to date.
For the second week in a row, General Electric ranked as the worst performing stock among the 30 equities that comprise the Dow index. In fact, GE widened the gap between itself and number 2 P&G.
Analysts at Jefferies have come up with a list of four pharmaceuticals stocks that may be good investments for a time of uncertainty in global markets.
General Electric ended Procter & Gamble's run as the worst performing Dow stock last week. GE shares dropped more than 1% for the week.
The worst-performing Dow 30 stock for the year to date remains consumer products giant Procter & Gamble.
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the top companies are starting to apply...
Procter & Gamble shares added more than 1% last week but that was not enough to allow the consumer products giant to relinquish its position as the worst performing Dow stock of the year to date.
Exxon Mobil, Chevron, Johnson & Johnson, and JPMorgan led the Dow to a lower close Thursday.
The Dow's worst performing stock for the past 5 weeks has been consumer products giant Procter & Gamble. Last week was an uneventful one for the company as the stock ticked up just 0.1 points.
This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.
The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received complaints against for obstructing development of generic versions of...